Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase I Study of Thiotepa in Combination with the Glutathione Transferase Inhibitor Ethacrynic Acid

Peter J. O'Dwyer, Frank LaCreta, Sherri Nash, Peter W. Tinsley, Russell Schilder, Margie L. Clapper, Kenneth D. Tew, Lisa Panting, Samuel Litwin, Robert L. Comis, Robert F. Ozols

Cancer Res (1991) 51 (22): 6059–6065.

Published: 01 November 1991

View article titled, Phase I Study of Thiotepa in Combination with the Glutathione Transferase Inhibitor Ethacrynic Acid

Journal Articles

Phase I/Pharmacokinetic Reevaluation of ThioTEPA

Peter J. O'Dwyer, Frank LaCreta, Paul F. Engstrom, Ruth Peter, Laura Tartaglia, Diane Cole, Samuel Litwin, Joseph DeVito, David Poplack, Robert J. DeLap, Robert L. Comis

Cancer Res (1991) 51 (12): 3171–3176.

Published: 01 June 1991

View article titled, Phase I/Pharmacokinetic Reevaluation of ThioTEPA

Journal Articles

Pharmacokinetic Study of Trimetrexate in Combination with Cisplatin

Gary R. Hudes, Frank LaCreta, Judy Walczak, Peter Tinsley, Samuel Litwin, Robert L. Comis, Peter J. O'Dwyer

Cancer Res (1991) 51 (12): 3080–3087.

Published: 01 June 1991

View article titled, Pharmacokinetic Study of Trimetrexate in Combination with Cisplatin

Journal Articles

Phase I Pharmacokinetic Study of Intraperitoneal Etoposide

Peter J. O'Dwyer, Frank P. LaCreta, J. Patrick Daugherty, Michael Hogan, Norman G. Rosenblum, Joyce L. O'Dwyer, Robert L. Comis

Cancer Res (1991) 51 (8): 2041–2046.

Published: 01 April 1991

View article titled, Phase I Pharmacokinetic Study of Intraperitoneal Etoposide

Journal Articles

Phase I Evaluation of an Anti-Breast Carcinoma Monoclonal Antibody 260F9-Recombinant Ricin A Chain Immunoconjugate

Louis M. Winer, Joyce O'Dwyer, Joanne Kitson, Robert L. Comis, Arthur E. Frankel, Robert J. Bauer, Michael S. Konrad, Eric S. Groves

Cancer Res (1989) 49 (14): 4062–4067.

Published: 01 July 1989

View article titled, Phase I Evaluation of an Anti-Breast Carcinoma Monoclonal Antibody 260F9-Recombinant Ricin A Chain Immunoconjugate

Journal Articles

A Phase I Study of Recombinant Interleukin 2 plus Recombinant β-Interferon

Robert L. Krigel, Kristin A. Padavic-Shaller, Alfred R. Rudolph, Samuel Litwin, Michael Konrad, Edward C. Bradley, Robert L. Comis

Cancer Res (1988) 48 (13): 3875–3881.

Published: 01 July 1988

View article titled, A Phase I Study of Recombinant Interleukin 2 plus Recombinant β-Interferon

Journal Articles

Antibody Delivery and Effector Cell Activation in a Phase II Trial of Recombinant γ-Interferon and the Murine Monoclonal Antibody CO17-1A in Advanced Colorectal Carcinoma

Louis M. Weiner, Philip J. Moldofsky, Robert A. Gatenby, Joyce O'Dwyer, Jacqueline O'Brien, Samuel Litwin, Robert L. Comis

Cancer Res (1988) 48 (9): 2568–2573.

Published: 01 May 1988

View article titled, Antibody Delivery and Effector Cell Activation in a Phase II Trial of Recombinant γ-Interferon and the Murine Monoclonal Antibody CO17-1A in Advanced Colorectal Carcinoma

Journal Articles

Noncorrelation of the Expression of the c-myc Oncogene in Colorectal Carcinoma with Recurrence of Disease or Patient Survival

Michael D. Erisman, Samuel Litwin, Richard D. Keidan, Robert L. Comis, Susan M. Astrin

Cancer Res (1988) 48 (5): 1350–1355.

Published: 01 March 1988

View article titled, Noncorrelation of the Expression of the c-<em>myc</em> Oncogene in Colorectal Carcinoma with Recurrence of Disease or Patient Survival

Journal Articles

Divergent Dose-related Effects of γ-Interferon Therapy on in Vitro Antibody-dependent Cellular and Nonspecific Cytotoxicity by Human Peripheral Blood Monocytes

Louis M. Weiner, Zenon Steplewski, Hilary Koprowski, Samuel Litwin, Robert L. Comis

Cancer Res (1988) 48 (4): 1042–1046.

Published: 01 February 1988

View article titled, Divergent Dose-related Effects of γ-Interferon Therapy on <em>in Vitro</em> Antibody-dependent Cellular and Nonspecific Cytotoxicity by Human Peripheral Blood Monocytes

Journal Articles

Small Cell Lung Cancer Cell Line Derived from a Primary Tumor with a Characteristic Deletion of 3p

Stephen L. Graziano, Bennet Y. Cowan, Desmond N. Carney, Christine R. Bryke, Navnit S. Mitter, Bruce E. Johnson, George E. Mark, Antonio T. Planas, Joseph J. Catino, Robert L. Comis, Bernard J. Poiesz

Cancer Res (1987) 47 (8): 2148–2155.

Published: 01 April 1987

View article titled, Small Cell Lung Cancer Cell Line Derived from a Primary Tumor with a Characteristic Deletion of 3p

Journal Articles

A Phase I and Clinical Pharmacology Study of Intravenously Administered Carminomycin in Cancer Patients in the United States

Robert L. Comis, Brian F. Issell, Kenneth Pittman, Sandra J. Ginsberg, Alfred Rudolph, John C. Aust, Santo M. DiFino, Roger W. Tinsley, Bernard J. Poiesz, Stanley T. Crooke

Cancer Res (1982) 42 (7): 2944–2948.

Published: 01 July 1982

View article titled, A Phase I and Clinical Pharmacology Study of Intravenously Administered Carminomycin in Cancer Patients in the United States

Journal Articles

Detection of a Serum DNA-binding Protein Associated with Cancer

Louis Galvan, John E. Evans, Robert L. Comis, Arlan Gottlieb, Ferenc Gyorkey, Montague Lane, Archie W. Prestayko, Stanley T. Crooke

Cancer Res (1982) 42 (4): 1562–1566.

Published: 01 April 1982

View article titled, Detection of a Serum DNA-binding Protein Associated with Cancer

Journal Articles

Role of Single-Breath Carbon Monoxide-diffusing Capacity in Monitoring the Pulmonary Effects of Bleomycin in Germ Cell Tumor Patients

Robert L. Comis, Mitchell S. Kuppinger, Sandra J. Ginsberg, Stanley T. Crooke, Robert Gilbert, J. Howland Auchincloss, Archie W. Prestayko

Cancer Res (1979) 39 (12): 5076–5080.

Published: 01 December 1979

View article titled, Role of Single-Breath Carbon Monoxide-diffusing Capacity in Monitoring the Pulmonary Effects of Bleomycin in Germ Cell Tumor Patients

Journal Articles

Pharmacokinetics of the Protein Antitumor Antibiotic Neocarzinostatin after Bolus Injection in Humans

Robert L. Comis, Thomas W. Griffin, Vic Raso, Sandra J. Ginsberg

Cancer Res (1979) 39 (3): 757–761.

Published: 01 March 1979

View article titled, Pharmacokinetics of the Protein Antitumor Antibiotic Neocarzinostatin after Bolus Injection in Humans

NARROW

Phase I Study of Thiotepa in Combination with the Glutathione Transferase Inhibitor Ethacrynic Acid

Phase I/Pharmacokinetic Reevaluation of ThioTEPA

Pharmacokinetic Study of Trimetrexate in Combination with Cisplatin

Phase I Pharmacokinetic Study of Intraperitoneal Etoposide

Phase I Evaluation of an Anti-Breast Carcinoma Monoclonal Antibody 260F9-Recombinant Ricin A Chain Immunoconjugate

A Phase I Study of Recombinant Interleukin 2 plus Recombinant β-Interferon

Antibody Delivery and Effector Cell Activation in a Phase II Trial of Recombinant γ-Interferon and the Murine Monoclonal Antibody CO17-1A in Advanced Colorectal Carcinoma

Noncorrelation of the Expression of the c-myc Oncogene in Colorectal Carcinoma with Recurrence of Disease or Patient Survival

Divergent Dose-related Effects of γ-Interferon Therapy on in Vitro Antibody-dependent Cellular and Nonspecific Cytotoxicity by Human Peripheral Blood Monocytes

Small Cell Lung Cancer Cell Line Derived from a Primary Tumor with a Characteristic Deletion of 3p

A Phase I and Clinical Pharmacology Study of Intravenously Administered Carminomycin in Cancer Patients in the United States

Detection of a Serum DNA-binding Protein Associated with Cancer

Role of Single-Breath Carbon Monoxide-diffusing Capacity in Monitoring the Pulmonary Effects of Bleomycin in Germ Cell Tumor Patients

Pharmacokinetics of the Protein Antitumor Antibiotic Neocarzinostatin after Bolus Injection in Humans

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only